Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment

1.

Worldwide burden of cancer attributable to diabetes and high body-mass index: a
comparative risk assessment
Jonathan Pearson-Stuttard, BMBCh, Bin Zhou, MSc, Vasilis Kontis, PhD, James Bentham, PhD, Marc J Gunter, PhD, Prof Majid Ezzati,
FMed Sci
The Lancet Diabetes & Endocrinology
DOI: 10.1016/S2213-8587(17)30366-2
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC
BY 4.0 license Terms and Conditions

2.

Figure 1
The Lancet Diabetes & Endocrinology DOI: (10.1016/S2213-8587(17)30366-2)
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC
BY 4.0 license Terms and Conditions

3.

Figure 2
The Lancet Diabetes & Endocrinology DOI: (10.1016/S2213-8587(17)30366-2)
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC
BY 4.0 license Terms and Conditions

4.

Figure 3
The Lancet Diabetes & Endocrinology DOI: (10.1016/S2213-8587(17)30366-2)
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC
BY 4.0 license Terms and Conditions